| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VASERETIC | 25MG 8MG | TABLET | Resolved | 2019-03-22 | 2019-04-26 | 79221 |
| VASERETIC | 8MG 25MG | TABLET | Resolved | 2020-04-24 | 2020-05-26 | 113158 |
| VASERETIC | 25MG 8MG | TABLET | Resolved | 2021-12-02 | 2022-02-01 | 150365 |
| VASERETIC | 25MG 8MG | TABLET | Avoided shortage | 2024-06-14 | 2024-08-23 | 230533 |
| VISKAZIDE | 25MG 10MG | TABLET | Resolved | 2021-12-15 | 2022-04-27 | 151232 |
| VISKAZIDE | 25MG 10MG | TABLET | Actual shortage | 2025-05-01 | 2025-10-27 | 256268 |
| VISKAZIDE | 50MG 10MG | TABLET | Resolved | 2021-12-15 | 2022-04-27 | 151235 |
| VISKAZIDE | 50MG 10MG | TABLET | Actual shortage | 2025-05-01 | 2025-10-27 | 256271 |
| ZESTORETIC | 12.5MG 10MG | TABLET | Resolved | 2023-06-19 | 2023-07-13 | 195535 |
| ZESTORETIC | 10MG 12.5MG | TABLET | Actual shortage | 2023-08-24 | 2026-01-07 | 202917 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40829 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40832 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 |